Capital World Investors, a registered investment adviser, initiated a new position in Thermo Fisher Scientific Inc. (NYSE:TMO) during Q4 2025, according to its most recent 13F…
Capital World Investors, a registered investment adviser, initiated a new position in Thermo Fisher Scientific Inc. (NYSE:TMO) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 11,003,814 shares of the Healthcare company, valued at approximately $6.4B as of the filing date.
Thermo Fisher Scientific Inc.'s stock currently trades at $511.10 with a market capitalization of $219.4B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NYSE · TMO
$651.45
Down: -$6.87 · -1.04%
Live quote updated
Keep reading
institutional ·
institutional ·
institutional ·
insider ·
